Vitrolife AB (publ)
OTC: VTRLY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Bronwyn Brophy O'Connor
- Employees
- 1,150
- Headquarters
- Gothenburg, Sweden
- IPO year
- 2016
- Market cap
- $1.4B
- Website
- https://www.vitrolife.com
Loading VTRLY…
Loading profile data…Frequently asked questions about VTRLY
What does Vitrolife AB (publ) (VTRLY) do?
Vitrolife AB (publ) is a Swedish medical technology company, established in 1994 and headquartered in Gothenburg. Its core business involves the development, manufacturing, and distribution of specialized products catering to assisted reproductive technologies (ART). The company offers a comprehensive portfolio that includes essential tools for...
Where does VTRLY trade?
Vitrolife AB (publ) (VTRLY) trades on the Other OTC.
What sector is VTRLY in?
Vitrolife AB (publ) (VTRLY) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Vitrolife AB (publ)?
Bronwyn Brophy O'Connor is the chief executive officer of Vitrolife AB (publ) (VTRLY).
Where is Vitrolife AB (publ) headquartered?
Vitrolife AB (publ) is headquartered in Sweden.
Does VTRLY pay a dividend?
Yes — Vitrolife AB (publ) (VTRLY) paid a trailing twelve-month dividend of USD 0.12 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did VTRLY go public?
Vitrolife AB (publ) (VTRLY) completed its initial public offering in 2016.
Is VTRLY an ADR?
Yes — VTRLY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Vitrolife AB (publ) reporting and dividends follow the underlying issuer.